Centro de Slaud Beatriz Velasco de Aleman
Mexico City, Mexico
NCT Number: NCT02611011
To determine if women can understand the instructions, carry out the test, and interpret the test results. Women will be recruited to complete a test instruction and comprehension assessment and a usability assessment.
Looking for future studies?
Notify Me10 year–50 year
Female
Observational
Mexico City, Mexico
To determine if women can understand the instructions, carry out the test, and interpret the test results. Women will be recruited to complete a test instruction and comprehension assessment and a usability assessment. Study participants will be a convenience sample of women seeking health services. Participants will first be asked to review the instructions for the Congo Red Dot Test and complete a short written questionnaire that assesses their comprehension of the test instructions. Participants will then be asked to perform the test using a test control and to interpret the results obtained by answering a second written questionnaire. After the woman performs the test, a healthcare provider will use a matched control to perform a second test.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The GV-005 is a simple test has been developed to detect unfolded or misfolded proteins in urine.
Time frame: within 5 minutes of reading test instructions
proportion of women who demonstrated various levels of understanding of the instructions for the CRD Test
Time frame: within 5 minutes of performing test
the proportion of women able to correctly use the CRD test
Gynuity Health Projects
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05802940
Aspirin, Behavior
Danville, Pennsylvania, United States
View Trial DetailsNCT07717931
Cardiovascular Diseases, Female Urogenital Diseases and Pregnancy Complications
Multan, Punjab Province, Pakistan
View Trial DetailsNCT07265336
Female Urogenital Diseases and Pregnancy Complications, Hypertension, Pregnancy-Induced
Panama City, Provincia de Panamá, Panama
View Trial DetailsNCT07040696
Acute Kidney Injury, Female Urogenital Diseases
Cairo, Giza Governorate, Egypt
View Trial Details